Lastly, it showed that MR redox signaling platform formation and associated NADPH oxidase activation were involved in NLRP3 inflammasome activation and thereby contributed to the development of NASH. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.